These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24346887)

  • 21. Eumycetoma pedis in an Albanian farmer.
    Fida M; Saraceno R; Gjylametaj N; Dervishi O; Barbullushi A; Kellici S; Vasili E
    Cutis; 2018 Nov; 102(5):E13-E15. PubMed ID: 30566558
    [No Abstract]   [Full Text] [Related]  

  • 22. Paecilomyces lilacinus eumycetoma.
    Motswaledi HM; Mathekga K; Sein PP; Nemutavhanani DL
    Int J Dermatol; 2009 Aug; 48(8):858-61. PubMed ID: 19659864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eumycetoma diagnosed in urban Australia.
    Kalatharan L; Kelley P
    Med J Aust; 2020 Feb; 212(3):107-107.e1. PubMed ID: 31872879
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mycetoma of the neck and the nape of the neck due to Madurella mycetomatis. Apropos of a case in Mauritania].
    Nozais JP; Canel MA; Datry A; Danis M
    Bull Soc Pathol Exot; 1995; 88(3):103-4. PubMed ID: 8555761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
    Mhmoud NA; Fahal AH; Mahgoub el S; van de Sande WW
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2959. PubMed ID: 24945499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A murine model of Madurella mycetomatis eumycetoma.
    Ahmed AO; van Vianen W; ten Kate MT; van de Sande WW; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
    FEMS Immunol Med Microbiol; 2003 Jun; 37(1):29-36. PubMed ID: 12770757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico.
    Nyuykonge B; Klaassen CHW; Zandijk WHA; de Hoog GS; Ahmed SA; Desnos-Ollivier M; Verbon A; Bonifaz A; van de Sande WWJ
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1828-1834. PubMed ID: 32233084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eumycetoma due to Madurella mycetomatis acquired in Jamaica.
    Fletcher CL; Moore MK; Hay RJ
    Br J Dermatol; 2001 Dec; 145(6):1018-21. PubMed ID: 11899126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects.
    Elkheir LYM; Haroun R; Mohamed MA; Fahal AH
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008307. PubMed ID: 32853199
    [No Abstract]   [Full Text] [Related]  

  • 30. Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the Madurella mycetomatis grain in mycetoma.
    Geneugelijk K; Kloezen W; Fahal AH; van de Sande WW
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2754. PubMed ID: 24675764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plantar Eumycetoma by Madurella mycetomatis in a heart-transplanted patient living in Portugal.
    Cunha N; Martins ML; Fradinho N; Martins P; Cabete J
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):e182-e183. PubMed ID: 29150882
    [No Abstract]   [Full Text] [Related]  

  • 32. Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.
    van de Sande WW; Fahal AH; Bakker-Woudenberg IA; van Belkum A
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2738-40. PubMed ID: 20350944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.
    Nenoff P; van de Sande WW; Fahal AH; Reinel D; Schöfer H
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1873-83. PubMed ID: 25726758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.
    Elfadil H; Fahal A; Kloezen W; Ahmed EM; van de Sande W
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003488. PubMed ID: 25768115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Madurella mycetoma: a neglected tropical disease.
    Baby P; Mohan V; Eapen M; Kurian A; Ramachandran A; Babu BC; Kumar A
    Clin Microbiol Infect; 2022 Mar; 28(3):375-376. PubMed ID: 33915283
    [No Abstract]   [Full Text] [Related]  

  • 36. Nigrograna mackinnonii, Not Trematosphaeria grisea (syn., Madurella grisea), Is the Main Agent of Black Grain Eumycetoma in Latin America.
    Ahmed SA; González GM; Tirado-Sánchez A; Moreno-López LM; de Hoog S; Bonifaz A
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma--A Retrospective Study.
    Verwer PE; Notenboom CC; Eadie K; Fahal AH; Verbrugh HA; van de Sande WW
    PLoS Negl Trop Dis; 2015; 9(9):e0004061. PubMed ID: 26332238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New species of Madurella, causative agents of black-grain mycetoma.
    de Hoog GS; van Diepeningen AD; Mahgoub el-S; van de Sande WW
    J Clin Microbiol; 2012 Mar; 50(3):988-94. PubMed ID: 22205798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan.
    Fahal A; Mahgoub el S; El Hassan AM; Abdel-Rahman ME
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003679. PubMed ID: 25816316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients.
    Nasr A; Abushouk A; Hamza A; Siddig E; Fahal AH
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004862. PubMed ID: 27434108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.